NCCInnovation | Advancing Sensory Classification with AI-Enabled Intraoperative Neuromonitoring

Shanghai, September 25, 2025 – Hosted by the National Innovation Center Par Excellence (NICE) and co-organized by the Shanghai United Center for Electrophysiology and Rehabilitation Innovation (NCC Neuro Research Center), the Midterm Review of the “AI-Based Automated Interpretation of Evoked Potential (EP) Waveforms in Intraoperative Neuromonitoring (IONM)” Program, together with the Launch Ceremony of the “Challenge-Driven” Project, was held at the NICE Building in Shanghai. The event brought together clinicians, researchers, and industry leaders to drive the intelligent advancement of IONM in China.

Smart Upgrade: AI-Assisted Analysis Marks a Milestone

To date, the project has collected and annotated more than 2,700 high-quality clinical cases. The AI model has demonstrated strong accuracy and stability in identifying key waveforms, including Evoked Potentials (EP) and Electromyography (EMG), laying a solid foundation for automated and objective intraoperative neurophysiological assessment.

This milestone represents a significant step forward in intelligent intraoperative neurophysiology and highlights the potential of this technology to enhance surgical safety and efficiency in the future.

Frontier Focus: Launch of the “Sensory Discrimination” Challenge Project

At the event, the “Challenge-Driven” project, “Research on Visualized Decision-Support Technology for Differential Sensory Function Monitoring,” was officially launched. Spearheaded by NCC Medical, the project was jointly undertaken by Prof. Shi-Ting Li’s neurosurgery team from Shanghai Xin Hua Hospital and other renowned neurosurgical experts.

“Sensory discrimination” remains one of the core challenges in neuromonitoring: accurately differentiating intraoperative signals of pain, touch, temperature, and proprioception. The ability to distinguish these modalities is critical for assessing nerve injury, guiding surgical maneuvers, and minimizing postoperative complications.

By integrating multi-modal signal acquisition with advanced AI algorithms, the project aims to build a visualized decision-support system. It represents a transformative leap—from monitoring motor function to perceiving sensory function—and positions Chinese clinical teams to move from keeping pace with global standards to leading the field.

Clinical Implementation: “NeuGuard” Ensures Full-Cycle Support

To support the effective adoption of IONM across clinical institutions, NCC Medical collaborates with the NeuGuard Clinical Support Team to provide comprehensive services to partner hospitals:

Tiered Training: From basic operation to advanced parameter configuration

On-Site Support: On-call engineers for high-risk or complex procedures

Remote Collaboration Platform: Cross-institutional case sharing and expert consultations

Joint Research Programs: Co-building real-world databases to support evidence-based studies

This operational model has been piloted in multiple hospitals nationwide, significantly improving clinical teams’ understanding and application of neuromonitoring systems.

NCC: 28 Years of Innovation in Electrophysiology

Since its founding in 1997, Shanghai NCC MEDICAL has remained committed to “clinical needs as the guide, technological innovation as the driver,” dedicating 28 years to advancing neural electrophysiology.

Electrophysiology: Pioneering and Breakthroughs (1997–2024)

Overcame the limitations of analog EEG and drove the transition to digital systems

Launched the world’s first wireless digital Bluetooth EEG in 2003, enabling mobile and real-time monitoring

Obtained NMPA registration for a 256-channel high-density ERP digital EEG system in 2023, enhancing cognitive function assessment

Listed in the Shanghai Innovative Medical Device Catalog in 2024

Intraoperative Protection (2010–2024)

Focused on intraoperative neural protection and built a self-reliant technological system

After over a decade of R&D, obtained China’s first self-developed Class III medical device registration for intraoperative neuromonitoring in 2024

Intelligent Future (2025 Onward)

NeuGuard INMC System: Breaks spatial barriers, enabling multi-level, multi-domain device connectivity and building a global collaborative network for neuromonitoring

AI-Powered Neuro Monitoring: Achieves automated ERP waveform annotation and trend-based early warnings, advancing from audible and visible to analyzable and predictive

Platform Synergy

Co-founded the Shanghai United Center for Electrophysiology and Rehabilitation Innovation (NCC Neuro Research Center) in 2011

Undertaken over 80 research projects, with more than 50 successfully commercialized, forming a closed-loop innovation ecosystem bridging industry, medicine, and research

NeuGuard Service Company: Established a professional platform connecting clinical neurophysiologists and experts nationwide, providing monitoring support, consultations, training, and multidisciplinary collaboration—ensuring expert-level protection for every high-risk surgery

Talent Development

In 2025, co-established the Electrophysiology Joint Innovation Academy

Cultivates interdisciplinary talent through a “real-problem, real-practice, industry-education integration” model, building a sustainable foundation for long-term growth

Looking Ahead

From overcoming the limitations of analog EEG to achieving self-reliance in intraoperative monitoring, from mobility to intelligent synergy, NCC has forged a path of independent innovation in China’s medical device industry.

Looking ahead, NCC Medical will further strengthen its integrated solution of “devices + consumables + software + services + education,” redefine the boundaries of neuromonitoring through technology, and empower Chinese high-end medical devices to compete globally.